PET/CT in Melanoma

Michael S. Hofman is a nuclear medicine physician and Associate Professor at the Centre for Cancer Imaging at the Peter MacCallum Cancer Centre in Melbourne, Australia's only public hospital dedicated to cancer treatment, research, and education. He previously completed a PET/CT and research fellowship at Guy's & St Thomas' in London. He has a broad interest in positron emission tomography (PET), molecular imaging applications in oncology, and radionuclide therapy, with a particular focus on novel PET radiotracers and theranostic applications, including neuroendocrine and prostate cancers. He currently serves as an associate editor for several journals, including Cancer Imaging, Journal of Medical Imaging and Radiation Oncology, and Leukemia Lymphoma.Rodney J. Hicks´is Professor of Medicine and Radiology at the University of Melbourne and Director of the Centre for Cancer Imaging at the Peter MacCallum Cancer Centre in Melbourne, Australia.

Select Guide Rating

• Melanoma.- Pathology.- Management.- Radiology.- PET/CT in Melanoma.- PET/CT in Melanoma: Normal  variations, artefacts and pitfalls.- PET/CT in Melanoma:Teaching Cases.